Alternative Name: ENG + EE Vaginal Ring
Description: EluRyng® is the first generic version of the NuvaRing®. It is a monthly vaginal ring, inserted for 3 weeks and removed for 1 week, with etonogestrel (ENG) and ethinyl estradiol (EE).
Delivery Method: Vaginal Ring
Duration Type: Short-acting
Duration: 1 month
- Inserted for 3 weeks and removed for 1 week
Dose: 0.120 mg ENG + 0.015 mg EE per day
Active Pharmaceutical Ingredient (API):
- ethinyl estradiol
Multipurpose Preventive Technology (MPT): No
Project Phase: Limited Market Availability
Development Stage: SRA/WHO PQ Approved
Active Development: Yes
- EluRyng® has received FDA approval.